EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY

Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Julie DUPOUY •  chercheure



2023
  1. Dupouy J, Chaneliere M, Schuers M, Laporte C, Bayen M, Gaultier A, Rat C. A face-to-face national congress experience during the COVID-19 pandemic: A report focussing on the risk of COVID-19 contamination. Eur J Gen Pract. 2023 Dec;29(2):2139825. doi: 10.1080/13814788.2022.2139825.
  2. Bouton C, Meziere P, Gaultier A, Dupouy J, Rat C; French National College of General Practioners. Identification of factors associated with non-adherence to recommended COVID-19 preventive behaviours: a cross-sectional study based on a survey among 1004 French primary care professionals. BMJ Open. 2023 Aug 29;13(8):e071215. doi: 10.1136/bmjopen-2022-071215.
  3. Sud A, Chiu K, Friedman J, Dupouy J. Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States. Int J Drug Policy. 2023 Aug 22;120:104161. doi: 10.1016/j.drugpo.2023.104161. Epub ahead of print.
2022
  1. Botton J, Semenzato L, Dupouy J, Dray-Spira R, Weill A, Saint-Lary O, Zureik M. No association of low-dose aspirin with severe COVID-19 in France: A cohort of 31.1 million people without cardiovascular disease. Res Pract Thromb Haemost. 2022 Jun 17;6(4):e12743. doi: 10.1002/rth2.12743.
     
  2. Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D; Coverage Study Group. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE). Clin Microbiol Infect. 2022 Jul;28(7):1010-1016. doi: 10.1016/j.cmi.2022.02.031.
     
  3. Fortin F, Roche S, Dupouy J, Bernard P, Lachal J, Lambert C, Laporte C. Barriers and Expectations of Adolescents Regarding the Identification and Management of Their Psychoactive Substance Use by Their General Practitioner. Int J Environ Res Public Health. 2022 Oct 14;19(20):13231. doi: 10.3390/ijerph192013231.
     
  4. Laporte C, Fortin F, Dupouy J, Quirin A, Pereira B, Chenaf C, Delorme J, Maynié-François C, Rat C, Birebent J, Rambaud J, Duale C, Kerckhove N, Delage N, Authier N. Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care. Int J Environ Res Public Health. 2022 Nov 11;19(22):14845. doi: 10.3390/ijerph192214845
     
  5. Lépine B, Debin M, Dassieu L, Gimenez L, Palmaro A, Ponté C, Swital M, Lapeyre-Mestre M, Blanchon T, Dupouy J. Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network. J Subst Abuse Treat. 2022 Dec;143:108891. doi: 10.1016/j.jsat.2022.108891.
     
  6. Lavergne J, Debin M, Blanchon T, Colizza V, Dassieu L, Gimenez L, Kengne-Kuetche C, Lapeyre-Mestre M, Dupouy J. Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France. Eur J Pain. 2022 Mar;26(3):729-739. doi: 10.1002/ejp.1901.
2021
  1. Boussac M, Arbus C, Dupouy J, Harroch E, Rousseau V, Croiset A, Ory-Magne F, Rascol O, Moreau C, Rolland AS, Maltête D, Rouaud T, Meyer M, Drapier S, Giordana B, Anheim M, Hainque E, Jarraya B, Benatru I, Auzou N, Belamri L, Tir M, Marques AR, Thobois S, Eusebio A, Corvol JC, Devos D, Brefel-Courbon C; PREDI-STIM study group. Personality dimensions of patients can change during the course of parkinson's disease. PLoS One. 2021 Jan 7;16(1):e0245142. doi: 10.1371/journal.pone.0245142.
     
  2. Fernández-Rodríguez B, Dupouy J, Harroch E, Fabre-Delcros MH, Barthélémy C, Loubière P, Barange K, Brefel-Courbon C, Rascol O, Ory-Magne F. Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulation. Rev Neurol (Paris). 2021 Oct;177(8):919-923. doi: 10.1016/j.neurol.2020.11.017
     
  3. Nguyen-Soenen J, Driot D, Verges Y, Dupouy J, Birebent J. Profil de délivrance des antidépresseurs chez l’enfant et l’adolescent en Midi-Pyrénées entre 2015 et 2017 [Patterns of antidepressant dispensing among children and adolescents between 2015 and 2017 in the French region of Midi-Pyrenees]. Rev Epidemiol Sante Publique. 2021. 69(1):7-12. French. doi: 10.1016/j.respe.2020.10.008.
     
  4. Rouillon M, Laporte C, Ingrand P, Castéra P, Di Patrizio P, Messaadi N, Binder P, Dupouy J. Perceptions, professional responsibility and management experiences of patients with alcohol, tobacco and opioid use disorder by residents in general practice and teaching general practitioners. Eur J Gen Pract. 2021 Dec;27(1):77-82. doi: 10.1080/13814788.2021.1917542.
     
  5. Santo T Jr, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, Chen A, Tran LT, Bharat C, Padmanathan P, Cousins G, Dupouy J, Kelty E, Muga R, Nosyk B, Min J, Pavarin R, Farrell M, Degenhardt L. Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021 Sep 1;78(9):979-993. doi: 10.1001/jamapsychiatry.2021.0976. Erratum in: JAMA Psychiatry. 2021 Sep 1;78(9):1044. Erratum in: JAMA Psychiatry. 2022 May 1;79(5):516.
2020
  1. Bigarré I, Landon C, Boyer P, Dupouy J. Reactivated world war two traumatic memories in COVID-19 lockdown period. Clin Case Rep. Clin Case Rep. 2020 Nov 29;9(2):609-11. doi: 10.1002/ccr3.3591.
     
  2. Driot D, Nguyen-Soenen J, Costes M, Pomier M, Birebent J, Oustric S, Dupouy J. Prise en charge de la dépression de l'enfant et l'adolescent en soins premiers : une métarevue systématique de la littérature.  Management of child and adolescents depression in primary care: a systematic meta-review. L’Encéphale 2020;46(1):41-54. doi : 10.1016/j.encep.2019.07.014.
     
  3. Costes S, Gimenez L, Comes A, Abdelnour X, Dupouy J, Escourou B. Discussing alcohol use with the general practitioner: a qualitative study. British Journal of General Practice Open 2020;4(2):bjgpopen20X101029.  doi: https://doi.org/10.3399/bjgpopen20X101029.
     
  4. Dupouy J, Maumus-Robert S, Mansiaux Y, Pariente A, Lapeyre-Mestre M. Primary Care of Opioid use Disorder: The End of "the French Model"? Eur Addict Res. 2020;26(6):346-354. doi: 10.1159/000506630.
     
  5. Escourrou E, Bergeaut M, Gimenez L, Durliat I, Stillmunkés A, Oustric S, Dupouy J. Evolution of Reactions to Uncertainty Among Residents During a Clinical Rotation. Fam Med. 2020 May;52(5):339-345. doi: 10.22454/FamMed.2020.403807.
     
  6. Escourrou E, Durrieu F, Chicoulaa B, Dupouy J, Oustric S, Andrieu S, Gardette V. Cognitive, functional, physical, and nutritional status of the oldest old encountered in primary care: a systematic review. BMC Fam Pract. 2020 Mar 27;21(1):58. doi: 10.1186/s12875-020-01128-7.
     
  7. Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D; COVERAGE study group. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 2020 Oct 13;21(1):846. doi: 10.1186/s13063-020-04619-1.
     
  8. Gimenez L, Dupouy J, Chicoulaa B, Ricordeau P, Rougé-Bugat ME, Oustric S. Innovative healthcare organization to deal with COVID-19 in primary health care in the Haute-Garonne department, France. Annals of Family Medicine, COVID-19 Collection. May 2020. Lire
     
  9. Nguyen-Soenen J, Driot D, Verges Y, Dupouy J, Birebent J. Profil de délivrance des antidépresseurs chez l’enfant et l’adolescent en Midi-Pyrénées entre 2015 et 2017 [Patterns of antidepressant dispensing among children and adolescents between 2015 and 2017 in the French region of Midi-Pyrenees]. Rev Epidemiol Sante Publique. 2021 Feb;69(1):7-12. doi: 10.1016/j.respe.2020.10.008.
     
  10. Vergès Y, Driot D, Mesthé P, Rougé Bugat ME, Dupouy J, Poutrain JC. Collaboration Between GPs and Psychologists: Dissatisfaction from the Psychologists' Perspective-A Cross-Sectional Study. J Clin Psychol Med Settings. 2020 Jun;27(2):331-342. doi: 10.1007/s10880-019-09663-x.
2019
  1. Driot D, Jouanjus E, Oustric S, Dupouy J, Lapeyre-Mestre M. Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France. Br J Clin Pharmacol. 2019 Jun;85(6):1260-1269. doi: 10.1111/bcp.13892.
     
  2. Driot D, Ouhayoun S, Perinelli F, Grézy-Chabardès C, Birebent J, Bismuth M, Dupouy J. Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France. Therapie. 2019 Oct;74(5):537-546. doi: 10.1016/j.therap.2019.03.004.
     
  3. Jouanjus E, Lapeyre-Mestre M, Nodot M, Roussin A, Franchitto N, Boyes JP, Nasr N, Oustric S, Dupouy J. Teaching Basic Knowledge on Substance Use Disorders: The Impact of e-Learning on Health Professionals. Clin Ther. 2019 Oct;41(10):2154-2161. doi: 10.1016/j.clinthera.2019.07.012.